Terms: = Germ cell tumor AND ABL1, p150, 25, ENSG00000097007, P00519, v-abl, bcr/abl, JTK7, c-ABL, ABL, BCR-ABL AND Treatment
6950 results:
1. Navigating diagnostic challenges-distinguishing malignant melanoma and clear cell sarcoma of soft tissues: a case report and review of the literature.
Abdouh S; Boujguenna I; Soleh A; Abkari I; Rais H
J Med Case Rep; 2024 May; 18(1):249. PubMed ID: 38755643
[TBL] [Abstract] [Full Text] [Related]
2. Sporadic subependymal giant cell astrocytoma with somatic
Alassiri AH; Alfayea TM; Aljared TI; Alenezi KR
Neurosciences (Riyadh); 2024 May; 29(2):139-143. PubMed ID: 38740392
[TBL] [Abstract] [Full Text] [Related]
3. Understanding supported self-management for people living with a lower-grade glioma: Implementation considerations through the lens of normalisation process theory.
Rimmer B; Finch T; Balla M; Dutton L; Williams S; Lewis J; Gallagher P; Burns R; Araújo-Soares V; Menger F; Sharp L;
Health Expect; 2024 Jun; 27(3):e14073. PubMed ID: 38733245
[TBL] [Abstract] [Full Text] [Related]
4. Repeat Radiosurgery for Sporadic Vestibular Schwannoma After Primary Radiosurgical Failure: An International Multi-institutional Investigation.
Khandalavala KR; Herberg HA; Kay-Rivest E; Moore LS; Yancey KL; Marinelli JP; Lund-Johansen M; Kosaraju N; Lohse CM; Kutz W; Santa Maria PL; Golfinos JG; Kondziolka D; Carlson ML; Tveiten ØV; Link MJ
Otol Neurotol; 2024 Jun; 45(5):587-593. PubMed ID: 38728563
[TBL] [Abstract] [Full Text] [Related]
5. Clinical outcomes of adjuvant nivolumab in resected stage III melanoma: comparison of CheckMate 238 trial and real-world data.
Moser JC; Bhatia S; Amin A; Pavlick AC; Betts KA; Du EX; Poretta T; Shelley K; Srinivasan S; Sakkal LA; Palaia J; Lobo M; Pe Benito M; Linton JA; Chen Y; Xu C; Yin L; Sundar M; Weber J
Cancer Immunol Immunother; 2024 May; 73(7):116. PubMed ID: 38713408
[TBL] [Abstract] [Full Text] [Related]
6. Decoding the molecular landscape: A novel prognostic signature for uveal melanoma unveiled through programmed cell death-associated genes.
Liu Z; Yu L; Lai J; Zhang R
Medicine (Baltimore); 2024 May; 103(18):e38021. PubMed ID: 38701273
[TBL] [Abstract] [Full Text] [Related]
7. Characterizing the presentation, management, and clinical outcomes of patients with intradural spinal chordomas: a systematic review.
Saint-Germain MA; Kramer P; Weber-Levine C; Jiang K; Al-Mistarehi AH; Redmond KJ; Lee SH; Bettegowda C; Theodore N; Lubelski D
Neurosurg Focus; 2024 May; 56(5):E14. PubMed ID: 38691865
[TBL] [Abstract] [Full Text] [Related]
8. Optimizing radiotherapy strategies for skull base chordoma: a comprehensive meta-analysis and systematic review of treatment modalities and outcomes.
Palavani LB; Borges P; Andreão FF; Borges J; Batista S; Oliveira LB; Ferreira MY; Reis PCA; Pontes J; Negri H; Beer-Furlan A; Krishna C; Bertani R; Rassi MS
Neurosurg Focus; 2024 May; 56(5):E11. PubMed ID: 38691862
[TBL] [Abstract] [Full Text] [Related]
9. Supramarginal resection of skull base chordomas: proof of concept and preliminary outcomes.
Rychen J; Constanzo F; Xu Y; Johnstone TM; Bex A; Rinaldi M; Lee CK; Fernandez-Miranda JC
Neurosurg Focus; 2024 May; 56(5):E3. PubMed ID: 38691859
[TBL] [Abstract] [Full Text] [Related]
10. Quality of life in chordoma survivors: results from the Chordoma Foundation Survivorship Survey.
Jimenez AE; Cicalese KV; Jimenez MA; Chakravarti S; Kuo CC; Lozinsky S; Schwab JH; Knowlton SE; Rowan NR; Mukherjee D
Neurosurg Focus; 2024 May; 56(5):E12. PubMed ID: 38691854
[TBL] [Abstract] [Full Text] [Related]
11. Long-term outcome of primary clival chordomas: a single-center retrospective study with an emphasis on the timing of recurrences based on the primary treatment.
Hong S; Shinya Y; Mahajan A; Laack NN; O'Brien EK; Stokken JK; Janus JR; Raghunathan A; Link MJ; Van Gompel JJ
Neurosurg Focus; 2024 May; 56(5):E4. PubMed ID: 38691852
[TBL] [Abstract] [Full Text] [Related]
12. Efficacy and safety of neoadjuvant therapy in gastroenteropancreatic neuroendocrine neoplasms: A systematic review and meta-analysis.
Yan Y; Wu D; Wang W; Lv Y; Yang L; Liu Y; Dong P; Yu X
J Cancer Res Ther; 2024 Apr; 20(2):633-641. PubMed ID: 38687934
[TBL] [Abstract] [Full Text] [Related]
13. D-Loop Mutations as Prognostic Markers in Glioblastoma-A Pilot Study.
Szmyd B; Stanisławska P; Podstawka M; Zaczkowski K; Izbiński PM; Kulczycka-Wojdala D; Stawski R; Wiśniewski K; Janczar K; Braun M; Białasiewicz P; Jaskólski DJ; Bobeff EJ
Int J Mol Sci; 2024 Apr; 25(8):. PubMed ID: 38673919
[TBL] [Abstract] [Full Text] [Related]
14. Survival Outcome Prediction in Glioblastoma: Insights from MRI Radiomics.
Styliara EI; Astrakas LG; Alexiou G; Xydis VG; Zikou A; Kafritsas G; Voulgaris S; Argyropoulou MI
Curr Oncol; 2024 Apr; 31(4):2233-2243. PubMed ID: 38668068
[No Abstract] [Full Text] [Related]
15. Radiotherapy plus temozolomide with or without anlotinib in H3K27M-mutant diffuse midline glioma: A retrospective cohort study.
Liu C; Kuang S; Huang T; Wu J; Zhang L; Gong X
CNS Neurosci Ther; 2024 Apr; 30(4):e14730. PubMed ID: 38644565
[TBL] [Abstract] [Full Text] [Related]
16. Prognostic significance of systemic inflammatory parameters in high-grade glial tumor patients: Two center experience.
Oztep Eskici S; Yilmaz EB
Medicine (Baltimore); 2024 Apr; 103(16):e37726. PubMed ID: 38640334
[TBL] [Abstract] [Full Text] [Related]
17. Risk factors for postoperative fever after laparoscopic adrenalectomy focusing on hormones produced: a case control study.
Izawa M; Takeda T; Anno T; Iwasawa T; Yasumizu Y; Tanaka N; Matsumoto K; Morita S; Kosaka T; Mizuno R; Asanuma H; Oya M
BMC Urol; 2024 Apr; 24(1):90. PubMed ID: 38637748
[TBL] [Abstract] [Full Text] [Related]
18. Relationship between chemokine/chemokine receptor and glioma prognosis and outcomes: Systematic review and meta-analysis.
Yang S; Luo M; Yang S; Yuan M; Zeng H; Xia J; Wang N
Int Immunopharmacol; 2024 May; 133():112047. PubMed ID: 38631221
[TBL] [Abstract] [Full Text] [Related]
19. Laser interstitial thermal therapy for recurrent glioblastomas: a systematic review and meta-analysis.
Zhao X; Li R; Guo Y; Wan H; Zhou D
Neurosurg Rev; 2024 Apr; 47(1):159. PubMed ID: 38625588
[TBL] [Abstract] [Full Text] [Related]
20. Cabozantinib in patients with unresectable and progressive metastatic phaeochromocytoma or paraganglioma (the Natalie Trial): a single-arm, phase 2 trial.
Jimenez C; Habra MA; Campbell MT; Tamsen G; Cruz-Goldberg D; Long J; Bassett R; Dantzer R; Balderrama-Brondani V; Varghese J; Lu Y
Lancet Oncol; 2024 May; 25(5):658-667. PubMed ID: 38608693
[TBL] [Abstract] [Full Text] [Related]
[Next]
